TITLE

Early infusion of high-dose omeprazole before endoscopy reduced the need for endoscopic therapy: COMMENTARY

AUTHOR(S)
Howden, Colin W.; Leontiadis, Grigoris I.
PUB. DATE
July 2007
SOURCE
ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p18
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors reflect on a study, conducted by J.Y. Lau and colleagues, which discusses how early intravenous (IV) infusion of high-dose omeprazole before endoscopy affects the need for endoscopic therapy in patients with bleeding peptic ulcers. The authors view that the study by Lau and colleagues revealed that active bleeding and the need for endoscopic therapy was reduced if the patients were administered with high dose of omeprazole before endoscopy.
ACCESSION #
25913658

 

Related Articles

  • Omeprazole to prevent ulcer re-bleeding.  // Caribbean Health;Dec2000, Vol. 3 Issue 4, p20 

    The article reports on the role of intravenous (i.v.) omeprazole in preventing ulcer re-bleeding. It notes that after endoscopic treatment of bleeding peptic ulcers recurrent bleeding is a problem. A sum of 240 patients were treated endoscopically with adrenaline injection and thermocoagulation...

  • Early infusion of high-dose omeprazole before endoscopy reduced the need for endoscopic therapy.  // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p18 

    The article cites a study, conducted by J.Y. Lau and colleagues, which discusses how early intravenous (IV) infusion of high-dose omeprazole before endoscopy affects the need for endoscopic therapy in patients with bleeding peptic ulcers. The researchers used randomized placebo-controlled trial...

  • The Effect of Endoscopic Therapy in Patients Receiving Omeprazole for Bleeding Ulcers with Nonbleeding Visible Vessels or Adherent Clots. Sung, Joseph J.Y.; Chan, Francis K.L.; Lau, James Y.W.; Man-Yee Yung; Wai-Keung Leung; Wu, Justin C.Y.; Ng, Enders K.W.; Sydney Chung, S.C. // Annals of Internal Medicine;8/19/2003, Vol. 139 Issue 4, p237 

    Focuses on the effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots. Effect of endoscopic treatment on bleeding from peptic ulcers; Different approaches of treating bleeding from a peptic ulcer patients; Method of...

  • CLINICAL EFFECTIVENESS OF IV OMEPRAZOLE IN ENDOSCOPICALLY TREATED PEPTIC ULCERS. Donnellan, C.F.; Clements, D.G.; Watt, A.L.; Healey, C.J. // Gut;Apr2003 Supplement 1, Vol. 52, pA114 

    Introduction: Airedale Hospital is a DGH serving a population of 200 000 in North and West Yorkshire. Publication of RCT data has recently demonstrated significant benefits of a 72 hour IV omeprazole infusion, for patients with peptic ulcers who undergo endoscopic haemostasis. This therapy was...

  • Eradication of Helicobacter pylori Reduces the Rate of Duodenal Ulcer Rebleeding: A Long-Term Follow-Up Study. Macri, Giuseppe; Milani, Stefano; Surrenti, Elisabeth; Passaleva, Maria Teresa; Salvadori, Giuseppe; Surrenti, Calogero // American Journal of Gastroenterology;Jun1998, Vol. 93 Issue 6, p925 

    Objectives: The long-term efficacy of Helicobacter pylori eradication to reduce the rate of recurrence of peptic ulcer bleeding is still uncertain. We evaluated the rate of duodenal ulcer rebleeding for 48 months after H. pylori eradication. Methods: Thirty-two male patients...

  • Effects of Intravenous and Oral Esomeprazole in the Prevention of Recurrent Bleeding from Peptic Ulcers after Endoscopic Therapy. Sung, Joseph JY; Suen, Bing-Yee; Wu, Justin CY; Lau, James YW; Ching, Jessica YL; Lee, Vivian WY; Chiu, Philip WY; Tsoi, Kelvin KF; Chan, Francis KL // American Journal of Gastroenterology;Jul2014, Vol. 109 Issue 7, p1005 

    OBJECTIVES:The use of intravenous proton-pump inhibitors (PPIs) has shown to reduce recurrent bleeding and improve patient outcome after endoscopic hemostasis on patients with peptic ulcer. However, the efficacy of oral PPI is uncertain. Studies from Asia indicated that even oral PPI can achieve...

  • A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer. Khoshbaten, Manouchehr; Fattahi, Ebrahim; Naderi, Nosratollah; Khaleghian, Farzaneh; Rezailashkajani, Mohammadreza // BMC Gastroenterology;2006, Vol. 6, p2 

    Background: Gastrointestinal bleeding is a common problem and its most common etiology is peptic ulcer disease. Ulcer rebleeding is considered a perilous complication for patients. To reduce the rate of rebleeding and to fasten the improvement of patients' general conditions, most emergency...

  • Recurrent Ulcer Bleeding: Is Intravenous Omeprazole the Solution? Nehme, Omar; Barkin, Jamie S.; Johnson, David // American Journal of Gastroenterology;Feb2001, Vol. 96 Issue 2, p594 

    In this randomized, double-blinded, placebo-controlled study, 240 patients who underwent successful endoscopic treatment for bleeding peptic ulcers were divided into two groups of 120 patients. One group received an 80-mg bolus of intravenous omeprazole followed by an infusion of omeprazole at 8...

  • One-Year Follow-up of Duodenal Ulcers after 1-Wk Triple Therapy for Helicobacter pylori. Sung, Joseph J. Y.; Chung, S.C. Sydney; Ling, Thomas K. W.; Man Yee Yung; Cheng, Augustin F. B.; Hosking, Shorland W.; Li, Arthur K. C // American Journal of Gastroenterology;Feb1994, Vol. 89 Issue 2, p199 

    Objective: to study the ulcer recurrence rate of Helicobacter pylori-positive duodenal ulcers at 1 yr after eradication of the bacteria by triple therapy. Method: Patients with H. pylori-positive duodenal ulcers were randomized to receive either triple therapy for 1 wk plus omeprazole for 4 wk...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics